Effect of fetal heart sounds on anxiety and pain during delivery
The Effect of Electro-fetal monıtorısıon Sound on Anxiety, paın and Postpartum
This study is testing if listening to fetal heartbeats can help reduce anxiety and pain for pregnant women in labor.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 128 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | Female |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06271889 on ClinicalTrials.gov |
What this trial studies
This study investigates how the sound of fetal heartbeats affects anxiety, pain levels, and postpartum bonding in pregnant women during the first phase of labor. Pregnant women aged 18-35 who are in active labor will be randomly assigned to either an intervention group, which will listen to fetal heart sounds, or a control group. Both groups will undergo routine monitoring and assessments of their anxiety and pain levels before and after the intervention. The goal is to determine if exposure to fetal sounds can help reduce anxiety and pain during delivery.
Who should consider this trial
Good fit: Ideal candidates are first-time pregnant women aged 18-35, at 38-42 weeks of gestation, with a single pregnancy in the vertex position.
Not a fit: Patients who are multiparous, have systemic diseases affecting delivery, or are outside the specified gestational age will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved labor experiences for pregnant women by reducing anxiety and pain.
How similar studies have performed: While similar studies exploring the impact of auditory stimuli during labor exist, this specific approach using fetal heart sounds is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Who are december the age range of 18- 35, * The least literate, * Which is the primiparous, * who is at the 38-42 week of gestation * With a single pregnancy in the vertex position, * Who does not have a systemic disease that will interfere with normal delivery (gestational diabetes, preeclampsia, etc.), * Who is in the active phase of labor \* Pregnant women who have agreed to participate in the study and received informed consent will be included in the study Exclusion Criteria: * 37. week 42. not between the weeks dec * It is a multipart, * Anyone who has any problems with communication, * Who has ceased to be involved in the study, * An unexpected complication develops (cesarean section of the pregnant woman, development of fetal distress in the fetus, etc.). * Oxytocin induction is applied Pregnant women who have been given pain medication (Aldolan, diazem) are
Where this trial is running
Istanbul
- Saglık Bilimleri Universitesi — Istanbul, Turkey (Recruiting)
Study contacts
- Study coordinator: Rojda BAYAR, Msc. Midwery
- Email: rojdabayar95@outlook.com
- Phone: +905393956925
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.